JP Patent

JP6231556B2 — Ｎ−［５−（３，５−ジフルオロ−ベンジル）−１ｈ−インダゾール−３−イル］−４−（４−メチル−ピペラジン−１−イル）−２−（テトラヒドロ−ピラン−４−イルアミノ）−ベンズアミドの調製方法

Assigned to ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ · Expires 2017-11-15 · 9y expired

What this patent protects

Patent listed against Rozlytrek.

Drugs covered by this patent

Patent Metadata

Patent number
JP6231556B2
Jurisdiction
JP
Classification
—
Expires
2017-11-15
Drug substance claim
No
Drug product claim
No
Assignee
ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.